Latest Ratings for CME
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Rosenblatt | Maintains | Neutral | |
| Mar 2022 | UBS | Maintains | Buy | |
| Mar 2022 | Credit Suisse | Maintains | Neutral |
Deep Dive Into CME Group Stock: Analyst Perspectives (17 Ratings)
Where Today's News Shapes Tomorrow
